INMD
InMode Ltd.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Neutral
-15/100
Last price
13.99
▼ 0.14 (0.99%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
14.14
Prev close
14.13
Day high
14.17
Day low
13.95
Volume
538.13K
Market cap
$805.04M
P/E (TTM)
11.56
52W range
12.72 – 16.74
Day trading desk
Gap from prior close
+0.07%
Prior close 14.13
VWAP
14.00
-0.10% from price
Relative volume
0.90×
Normal
Session range
1.72%
13.93 – 14.17
Position in range
25%
Near session low
ATR (14D)
0.18
1.26% of price
Prior day high
14.19
PDH
Prior day low
14.06
PDL
Bid / ask spread
—
Quote not published
Session volume
464.58K
Avg 519.02K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-1.62%
-3.6%
1M
-6.17%
-7.3%
3M
-3.25%
-7.8%
6M
+2.49%
-15.7%
YTD
-4.77%
-19.0%
1Y
-7.66%
-24.1%
3Y
-54.07%
-136.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on INMD open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
7.75M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 4, 26 | ITZKOVICH MOSHE Chief Financial Officer |
STOCK | 14.00K | $0 | Direct |
| Jul 30, 26 | NASS SHLOMO Director |
STOCK | 2.00K | $0 | Direct |
| Jul 30, 26 | KENNETH NADAV Director |
STOCK | 2.00K | $0 | Direct |
| Jul 30, 26 | RON HADAR Director |
STOCK | 2.00K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ITZKOVICH MOSHE |
Chief Financial Officer | 40.73K | Stock Award(Grant) |
KENNETH NADAV |
Director | 5.00K | Stock Award(Grant) |
NASS SHLOMO |
Director | 2.00K | Stock Award(Grant) |
RON HADAR |
Director | 60.27K | Stock Award(Grant) |
Fundamentals
Market cap$805.04M
Enterprise value$327.39M
Revenue (TTM)$374.62M
Gross profit$286.68M
EBITDA$71.15M
Net income$77.51M
EPS (TTM)$1.21
Free cash flow$47.40M
Total cash$501.12M
Total debt$4.45M
Book value / share$10.68
Shares outstanding57.54M
Float49.12M
Short % of float4.64%
Dividend yield0.00%
Beta (5Y)2.03
Valuation & profitability ratios
Trailing P/E11.56
Forward P/E10.20
PEG ratio0.83
Price / sales—
Price / book1.31
EV / revenue0.87
EV / EBITDA4.60
Gross margin76.52%
Operating margin12.82%
Profit margin20.69%
Return on equity12.33%
Return on assets6.17%
Debt / equity0.71
Current ratio8.18
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $370.50M | $394.82M | $492.05M | $454.27M | -6.2% |
| Operating revenue | $370.50M | $394.82M | $492.05M | $454.27M | -6.2% |
| Cost of revenue | $79.53M | $77.75M | $80.71M | $73.48M | +2.3% |
| Gross profit | $290.97M | $317.07M | $411.34M | $380.79M | -8.2% |
| Research & development | $13.32M | $13.14M | $13.41M | $12.43M | +1.4% |
| Selling, general & admin | $192.26M | $191.40M | $202.27M | $170.51M | +0.5% |
| Total operating expense | $205.58M | $204.53M | $215.68M | $182.93M | +0.5% |
| Operating income | $85.39M | $112.53M | $195.66M | $197.85M | -24.1% |
| Net interest income | $24.94M | $30.94M | $21.61M | $3.61M | -19.4% |
| Pre-tax income | $110.33M | $143.47M | $217.27M | $201.47M | -23.1% |
| Tax provision | $16.50M | -$37.81M | $19.35M | $39.95M | +143.6% |
| Net income | $93.83M | $181.28M | $197.92M | $161.52M | -48.2% |
| Net income to common | $93.83M | $181.28M | $197.92M | $161.52M | -48.2% |
| Basic EPS | 1.45 | 2.29 | 2.37 | 1.96 | -36.7% |
| Diluted EPS | 1.43 | 2.25 | 2.30 | 1.89 | -36.4% |
| EBIT | $85.39M | $112.53M | $195.66M | $197.85M | -24.1% |
| EBITDA | $86.08M | $113.26M | $196.28M | $198.53M | -24.0% |
| Basic shares | 64.63M | 79.31M | 83.53M | 82.48M | -18.5% |
| Diluted shares | 65.44M | 80.60M | 85.95M | 85.40M | -18.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $302.54M | $155.33M | $144.41M | $97.54M | +94.8% |
| Cash & short-term investments | $555.33M | $596.47M | $741.61M | $547.38M | -6.9% |
| Accounts receivable | $43.50M | $36.34M | $42.36M | $27.00M | +19.7% |
| Inventory | $74.05M | $59.55M | $45.09M | $39.90M | +24.4% |
| Total current assets | $698.62M | $714.45M | $845.33M | $629.37M | -2.2% |
| Property, plant & equipment | $10.87M | $11.05M | $12.08M | $7.37M | -1.6% |
| Total assets | $766.43M | $785.67M | $863.29M | $644.41M | -2.4% |
| Total current liabilities | $70.74M | $69.85M | $64.14M | $82.02M | +1.3% |
| Total debt | $8.23M | $7.82M | $9.02M | $4.96M | +5.2% |
| Total liabilities | $83.23M | $81.85M | $75.91M | $89.79M | +1.7% |
| Retained earnings | $968.53M | $874.70M | $693.43M | $495.51M | +10.7% |
| Shareholder equity | $683.20M | $703.81M | $787.37M | $554.62M | -2.9% |
| Working capital | $627.88M | $644.60M | $781.19M | $547.35M | -2.6% |
| Net tangible assets | $683.20M | $703.81M | $787.37M | $554.62M | -2.9% |
| Shares issued | 88.33M | 87.58M | 85.96M | 84.52M | +0.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $93.83M | $181.28M | $197.92M | $161.52M | -48.2% |
| Depreciation & amortisation | $695.00K | $728.00K | $623.00K | $680.00K | -4.5% |
| Stock-based compensation | $11.13M | $16.57M | $23.60M | $24.45M | -32.8% |
| Change in working capital | -$24.30M | -$7.07M | -$41.44M | -$4.47M | -243.8% |
| Operating cash flow | $85.26M | $132.66M | $176.83M | $181.58M | -35.7% |
| Capital expenditure | -$972.00K | -$669.00K | -$705.00K | -$1.57M | -45.3% |
| Investing cash flow | $186.03M | $162.21M | -$136.06M | -$109.47M | +14.7% |
| Share buybacks | -$127.44M | -$285.38M | $0 | -$42.64M | +55.3% |
| Financing cash flow | -$126.06M | -$282.77M | $5.50M | -$41.09M | +55.4% |
| Free cash flow | $84.28M | $132.00M | $176.12M | $180.00M | -36.1% |
| End cash position | $302.54M | $155.33M | $144.41M | $97.54M | +94.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $95.59M | $82.02M | $103.85M | $93.17M | $95.60M | +16.5% |
| Operating revenue | $95.59M | $82.02M | $103.85M | $93.17M | $95.60M | +16.5% |
| Cost of revenue | $24.07M | $20.46M | $22.55M | $20.86M | $19.15M | +17.6% |
| Gross profit | $71.52M | $61.55M | $81.30M | $72.31M | $76.45M | +16.2% |
| Research & development | $3.66M | $3.54M | $3.51M | $3.54M | $3.37M | +3.2% |
| Selling, general & admin | $55.60M | $47.95M | $51.80M | $47.87M | $50.20M | +16.0% |
| Total operating expense | $59.26M | $51.50M | $55.31M | $51.41M | $53.57M | +15.1% |
| Operating income | $12.26M | $10.06M | $25.99M | $20.90M | $22.88M | +21.9% |
| Net interest income | $7.43M | $4.30M | $5.30M | $4.72M | $8.06M | +73.0% |
| Pre-tax income | $19.69M | $14.35M | $31.29M | $25.62M | $30.94M | +37.2% |
| Tax provision | $2.63M | $2.79M | $4.27M | $3.75M | $4.20M | -5.9% |
| Net income | $17.06M | $11.56M | $27.02M | $21.86M | $26.74M | +47.6% |
| Net income to common | $17.06M | $11.56M | $27.02M | $21.86M | $26.74M | +47.6% |
| Basic EPS | 0.29 | 0.18 | 0.43 | 0.35 | 0.42 | +61.1% |
| Diluted EPS | 0.29 | 0.18 | 0.42 | 0.34 | 0.42 | +61.1% |
| EBIT | $12.26M | $10.06M | $25.99M | $20.90M | $22.88M | +21.9% |
| EBITDA | $12.44M | $10.23M | $26.16M | $21.05M | $23.07M | +21.6% |
| Basic shares | 58.90M | 63.40M | 63.34M | 63.29M | 63.25M | -7.1% |
| Diluted shares | 59.38M | 63.94M | 64.08M | 63.87M | 63.64M | -7.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $396.17M | $394.30M | $302.54M | $252.44M | $216.24M | +0.5% |
| Cash & short-term investments | $501.12M | $537.16M | $555.33M | $532.31M | $510.68M | -6.7% |
| Accounts receivable | $44.55M | $40.70M | $43.50M | $38.09M | $35.65M | +9.5% |
| Inventory | $71.66M | $71.41M | $74.05M | $71.40M | $68.11M | +0.4% |
| Total current assets | $650.00M | $680.78M | $698.62M | $666.29M | $638.78M | -4.5% |
| Property, plant & equipment | $11.32M | $11.23M | $10.87M | $11.16M | $11.56M | +0.8% |
| Total assets | $720.33M | $750.84M | $766.43M | $734.61M | $708.35M | -4.1% |
| Total current liabilities | $79.44M | $77.35M | $70.74M | $68.33M | $66.53M | +2.7% |
| Total debt | $4.45M | $4.83M | $8.23M | $5.59M | $6.10M | -7.8% |
| Total liabilities | $91.20M | $89.58M | $83.23M | $81.22M | $79.91M | +1.8% |
| Retained earnings | — | — | $968.53M | — | — | — |
| Shareholder equity | $629.13M | $661.25M | $683.20M | $653.38M | $628.44M | -4.9% |
| Working capital | $570.56M | $603.43M | $627.88M | $597.96M | $572.25M | -5.4% |
| Net tangible assets | $629.13M | $661.25M | $683.20M | $653.38M | $628.44M | -4.9% |
| Shares issued | 57.54M | 57.48M | 88.33M | 63.36M | 63.21M | +0.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $17.06M | $11.56M | $27.02M | $21.86M | $26.74M | +47.6% |
| Depreciation & amortisation | $179.00K | $175.00K | $174.00K | $156.00K | $191.00K | +2.3% |
| Stock-based compensation | $3.71M | $2.70M | $2.50M | $2.70M | $3.42M | +37.4% |
| Change in working capital | -$1.30M | -$621.00K | -$7.42M | -$4.11M | -$6.68M | -109.7% |
| Operating cash flow | $21.05M | $15.39M | $22.67M | $24.47M | $24.07M | +36.8% |
| Capital expenditure | -$211.00K | -$172.00K | -$534.00K | -$134.00K | -$219.00K | -22.7% |
| Investing cash flow | $37.68M | $109.10M | $27.22M | $11.67M | $71.66M | -65.5% |
| Share buybacks | -$56.51M | -$31.24M | $0 | $0 | -$27.48M | -80.9% |
| Financing cash flow | -$56.49M | -$32.43M | $137.00K | $249.00K | -$26.98M | -74.2% |
| Free cash flow | $20.84M | $15.21M | $22.14M | $24.33M | $23.85M | +37.0% |
| End cash position | $396.17M | $394.30M | $302.54M | $252.44M | $216.24M | +0.5% |
Options analytics
Put / call volume
21.81
Put-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
7.00
-50.0% from spot
ATM implied vol
0.4%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
16
Contracts, this expiry
Put volume
349
Contracts, this expiry
Heaviest call OI
7.00
0 contracts
Heaviest put OI
12.00
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.33 | 0.35 | +5.4% |
| Mar 2026 | 0.30 | 0.25 | -16.1% |
| Dec 2025 | 0.42 | 0.46 | +10.4% |
| Sep 2025 | 0.35 | 0.38 | +7.0% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.32 | 5 | $91.59M | -1.7% |
| Next quarter | 0.38 | 5 | $101.13M | -2.6% |
| Current year | 1.30 | 5 | $370.27M | -0.1% |
| Next year | 1.37 | 5 | $378.78M | +2.3% |
Analyst targets & ownership
Mean target$16.17
High target$17.00
Low target$15.00
Implied upside15.56%
Analyst count3
ConsensusNONE
Strong buy / Buy0 / 0
Hold5
Sell / Strong sell0 / 0
Held by insiders13.16%
Held by institutions55.96%
Institutions holding249
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
14.15
-1.13% from price
SMA 20
14.41
-2.89% from price
SMA 50
14.81
-5.54% from price
SMA 100
14.54
-3.80% from price
SMA 200
14.39
-2.78% from price
EMA 12
14.22
-1.61% from price
EMA 26
14.44
-3.11% from price
EMA 50
14.59
-4.09% from price
RSI (14)
29.5
Oversold
MACD (12,26,9)
-0.22
Hist -0.02
ATR (14)
0.18
1.26% of price
Realised vol 30D
11.1%
Annualised
Bollinger upper
15.00
20, 2σ
Bollinger lower
13.81
20, 2σ
50 / 200 cross
Golden
14.81 vs 14.39
Trend bias
Below 200
-2.78%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.70
Less volatile than market
Correlation to SPY
0.29
Largely independent
Realised vol 30D
11.1%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-23.2%
Peak to trough
Max drawdown 5Y
-87.0%
Peak to trough
ATR 14
0.18
1.26% of price
Beta (reported)
2.03
5Y monthly, from filing
Short interest
Shares short
2.36M
Prior 2.43M
Change vs prior
-3.0%
Shorts covering
% of float
4.64%
Normal
% of shares out
4.10%
Against total outstanding
Days to cover
4.9
Liquid
Float
49.12M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 7, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| May 7, 26 | Baird | MAINTAINED | Neutral | Neutral |
| Dec 17, 25 | Canaccord Genuity | MAINTAINED | Hold | Hold |
| Nov 6, 25 | UBS | MAINTAINED | Neutral | Neutral |
| Oct 10, 25 | Canaccord Genuity | MAINTAINED | Hold | Hold |
| Oct 10, 25 | Needham | MAINTAINED | Hold | Hold |
| Jul 30, 25 | Needham | MAINTAINED | Hold | Hold |
| Jul 30, 25 | Barclays | MAINTAINED | Overweight | Overweight |
| Jul 11, 25 | Canaccord Genuity | MAINTAINED | Hold | Hold |
| Apr 30, 25 | Barclays | MAINTAINED | Overweight | Overweight |
| Apr 29, 25 | UBS | MAINTAINED | Neutral | Neutral |
| Apr 29, 25 | BTIG | DOWNGRADE | Buy | Neutral |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split2:1
Split dateOct 1, 2021
SEC filings
Corporate Changes & Voting Matters
6-K · 2026-09-16
Corporate Changes & Voting Matters
6-K · 2026-08-11
Corporate Changes & Voting Matters
6-K · 2026-08-05
Corporate Changes & Voting Matters
6-K · 2026-08-03
Corporate Changes & Voting Matters
6-K · 2026-07-20
Corporate Changes & Voting Matters
6-K · 2026-07-13
Corporate Changes & Voting Matters
6-K · 2026-06-25
Corporate Changes & Voting Matters
6-K · 2026-06-24
Headlines
InMode Advances RF Microneedling Comfort with the Launch of Morpheus8 Cool
PR Newswire · 28d ago
A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture
CNW Group · 36d ago
InMode: Q2 Earnings Snapshot
Associated Press · 63d ago
InMode Reports Second Quarter 2026 Financial Results: Quarterly GAAP Revenues of $95.6 Million, Consistent with the Second Quarter of 2025
PR Newswire · 63d ago
Steel Partners Urges InMode Shareholders to Vote AGAINST the Re-Election of Dr. Hadar Ron and AGAINST Extraordinary Special Committee Compensation at the July 30 Annual General Meeting
Business Wire · 70d ago
Steel Partners Holdings L.P. Issues Letter to InMode Ltd. Board of Directors Regarding the Company’s Persistent and Egregious Governance Failures
Business Wire · 82d ago
Sector Update: Health Care Stocks Lower Early Monday
MT Newswires · 86d ago
Sector Update: Healthcare
MT Newswires · 86d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.